UBS Group AG

Position in TPST — Tempest Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in TPST

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,255

-$1,178 QoQ

Shares Held

5,636

+24.3% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#10

of 21 holders

Holding Since

Mar 2020

17 quarters on record

Voting authority Sole 45% Shared 0% None 55%

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,672,124 across 561 Biotechnology names. TPST ranks #466 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	5,450,825	$1,020,369,609
2	ROIV	Roivant Sciences Ltd.	17,466,641	$618,144,423
3	PTGX	Protagonist Therapeutics, Inc	3,399,221	$416,676,508
4	VRTX	Vertex Pharmaceuticals Inc / Ma	712,259	$353,800,411
5	MRNA	Moderna, Inc.	4,463,211	$312,558,664
6	INSM	INSMED Inc	2,584,446	$275,553,630
7	ABVX	Abivax S.A.	1,844,918	$245,853,771
8	MDGL	Madrigal Pharmaceuticals, Inc.	401,708	$215,697,109

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,255	5,636	+24.3%	Shares	Defined	2026-08-13
2026-03-31	$7,433	4,533	-74.2%	Shares	Defined	2026-05-05
2025-12-31	$50,344	17,542	+54.0%	Shares	Defined	2026-01-29
2025-09-30	$117,078	11,389	+1.5%	Shares	Defined	2025-11-13
2025-06-30	$76,316	11,223	-96.5%	Shares	Defined	2025-08-14
2025-03-31	$238,889	323,699	+65.4%	Shares	Defined	2025-05-13
2024-12-31	$163,388	195,676	+2230.9%	Shares	Defined	2025-02-14
2024-09-30	$11,752	8,395	+811.5%	Shares	Sole	2024-11-14
2024-03-31	$3,601	921	+246.2%	Shares	Sole	2024-05-13
2023-12-31	$1,170	266	-66.8%	Shares	Sole	2024-02-09
2023-06-30	$1,015	800	-72.1%	Shares	Defined	2023-08-11
2022-09-30	$4,992	2,869	-42.5%	Shares	Sole	2022-11-10
2022-06-30	$10,734	4,993	+407.9%	Shares	Sole	2022-08-10
2021-09-30	$14,224	983	+568.7%	Shares	Sole	2021-11-15
2021-06-30	$1,643	147	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.